Tolerance and efficacy of enteral nutrition in traumatic brain-injured patients induced into barbiturate coma

Grant V Bochicchio1, Kelly Bochicchio, Shelley Nehman

  • 1R. Adams Cowley Shock Trauma Center, Division of Clinical and Outcomes Research, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. gbochicchio@umm.edu

Insights

Enteral nutrition is ineffective in traumatic brain injury patients in barbiturate coma due to ileus. Parenteral nutrition should be considered early in this patient population for better outcomes.

Area of Science:

  • Critical Care Medicine
  • Neuroscience
  • Trauma Surgery

Background:

  • Limited data exists on nutrition support efficacy in traumatic brain injury (TBI) patients requiring barbiturate coma for refractory intracranial hypertension.
  • Evaluating enteral nutrition's effectiveness in this specific patient cohort is crucial.

Purpose of the Study:

  • To assess the efficacy of enteral nutrition in severe TBI patients induced into barbiturate coma.
  • To determine feeding tolerance and the impact of interventions like prokinetic agents and postpyloric feeding tubes.

Main Methods:

  • Prospective data collection over 4 years on severe TBI patients.
  • Stratification based on barbiturate coma induction (defined by American Association of Neurological Surgeons guidelines).
  • Initial enteral feeding via nasogastric tube, with prokinetic agents for intolerance; feeding tolerance defined by gastric residuals.

Main Results:

  • All 57 patients in barbiturate coma failed initial nasogastric enteral nutrition within 48 hours.
  • Prokinetic agents did not improve feeding tolerance in the subsequent 48-72 hours.
  • Only 25% of patients with a postpyloric feeding tube tolerated enteral nutrition for over 48 hours.

Conclusions:

  • TBI patients in barbiturate coma develop a refractory ileus, significantly hindering enteral nutrition.
  • Postpyloric feeding tubes offer only marginal improvement in feeding tolerance.
  • Early consideration of parenteral nutrition is recommended for this patient group.
Abstract

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...